What to Know About Hydroxychloroquine

President Trump revealed on Monday that he had been taking an anti-malaria drug as a preventive measure against the coronavirus, the same medicine that he has been promoting for two months with scant evidence of its efficacy and despite several warnings of dangerous side effects. The drug, hydroxychloroquine, has been invoked by Mr. Trump repeatedly…

Mount Sinai Health System and Renalytix form joint venture, Kantaro Biosciences, to develop and scale production of COVID antibody test kits

Mount Sinai Health System (“Mount Sinai”) and Renalytix AI (LSE: RENX) today announced the formation of Kantaro Biosciences, LLC (“Kantaro”), a Mount Sinai venture, to develop and scale production and distribution of a test kit based on the Mount Sinai-developed high-performance serologic assay for SARS-CoV-2 antibodies. Kantaro has partnered with Minneapolis-based Bio-Techne Corporation (NASDAQ: TECH)…

Parent-led discussion about mutual strengths benefits parent-teen communication

Philadelphia, May 19, 2020–A primary care-based intervention to promote parent-teen communication led to less distress and increased positive emotions among adolescents, as well as improved communication for many teens, according to a new study by researchers at the Center for Parent and Teen Communication at Children’s Hospital of Philadelphia (CHOP). The findings, which were published…

Researchers find potential drug treatment targets for alcohol-related liver disease

Alcohol-related liver disease (ALD) is a deadly condition affecting more than 150 million people worldwide with no treatment available besides transplant. But now, a team led by researchers from Massachusetts General Hospital (MGH) has uncovered key molecular step stones in ALD that may provide targets for drug therapy development. Their work was recently published in…

How to improve the pneumococcus vaccine

Washington, DC – May 19, 2020 — Vaccines that protect people from infection by Streptococcus pneumoniae, which kills up to 1 million children ever year worldwide, train the immune system to recognize the pathogen’s thick sugar capsule. Pneumococcus capsules are not only the active ingredient in vaccines; they’re also key to the pathogen’s virulence. But…

Researchers urge clinical trial of blood pressure drug to prevent complication of Covid-19

Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could–if given early enough–potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection. Prazosin, a U.S. Food and Drug Administration-approved alpha blocker that relaxes…